ORIC
Oric Pharmaceuticals
$8.27
Earnings Summary
Revenue | $0Mn |
Net Profits | $-25.48Mn |
Net Profit Margins | -Inf% |
Highlights
Oric Pharmaceuticals’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Oric Pharmaceuticals has generated NaN% jump in its revenue since last 3-months.
Oric Pharmaceuticals’s net profit fell -6.32% since last year same period to $-25.48Mn in the Q3 2023. On a quarterly growth basis, Oric Pharmaceuticals has generated -11.04% fall in its net profits since last 3-months.
Oric Pharmaceuticals’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Oric Pharmaceuticals has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Oric Pharmaceuticals post its latest quarter earnings
EPS Estimate Current Quarter | -0.48 |
EPS Estimate Current Year | -0.48 |
Highlights
Oric Pharmaceuticals’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a -4.35% fall from last quarter’s estimates.
Oric Pharmaceuticals’s earning per share (EPS) estimates for the current year stand at -0.48.
Key Ratios
Key ratios of the Oric Pharmaceuticals post its Q3 2023 earnings
Earning Per Share (EPS) | -0.44 |
Highlights
Oric Pharmaceuticals’s earning per share (EPS) jumped 30.16% since last year same period to -0.44 in the Q3 2023. This indicates that the Oric Pharmaceuticals has generated 30.16% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-06 | -0.46 | -0.44 | 4.35% |
2023-05-08 | -0.54 | -0.53 | 1.85% |
2023-08-10 | -0.57 | -0.5 | 12.28% |
₹0 US Stocks a/c Opening Fee